The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea
A life-threatening asthma attack is still of major concern. One of the main goals in treating patients with asthma is identification of the patients at risk of having these attacks. It has been shown that patients who have a near-fatal asthma attack have a blunted perception of dyspnea (POD). The pu...
Gespeichert in:
Veröffentlicht in: | Chest 2002-02, Vol.121 (2), p.329-333 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 333 |
---|---|
container_issue | 2 |
container_start_page | 329 |
container_title | Chest |
container_volume | 121 |
creator | Magadle, Rasmi Berar-Yanay, Noa Weiner, Paltiel |
description | A life-threatening asthma attack is still of major concern. One of the main goals in treating patients with asthma is identification of the patients at risk of having these attacks. It has been shown that patients who have a near-fatal asthma attack have a blunted perception of dyspnea (POD). The purpose of this study is to measure the POD in patients with asthma, and to relate POD to life-threatening attacks within a 24-month follow-up period.
The POD was scored using the Borg scale during breathing against a progressive load at 1-min intervals, in order to achieve mouth pressure up to 30 cm H2O, in 113 consecutive asthmatic patients with stable asthma attending an outpatient clinic. All patients were invited to regular follow-up every 3 months for up to 24 months, and all hospitalizations and near-fatal and fatal asthma attacks were recorded. The prebronchodilator morning peak expiratory flow rate (PEFR), daily regular treatment, and β2-agonist consumption were recorded in a diary card for the first 4 weeks.
Seventeen patients (15%) had high POD compared to the normal subjects, 67 patients (59%) had POD within the normal range, and 29 patients (26%) had lower-than-normal POD. In the patients with low POD, there was a tendency for higher age, higher female/male ratio, and a longer duration of disease. The rate of severe asthma was higher in the low-POD group than in the normal-POD group, but did not differ from the rate in the high-POD group. The mean daily β2-agonist consumption in the patients with low POD was significantly lower (p < 0.01) than in the patients with high POD, although the mean PEFR was lower in the low-POD group. During the 2 years of follow-up, the patients in the low-POD group had statistically significantly more emergency department (ED) visits, hospitalizations, near-fatal asthma attacks, and deaths compared to the normal-POD and high-POD groups.
Approximately 26% of the referral subjects with asthma had low POD when compared to healthy matched subjects. Patients with low POD had statistically significantly more ED visits, hospitalizations, near-fatal asthma attacks, and deaths during the follow-up period. Reduced POD may predispose patients to a life-threatening attack. |
doi_str_mv | 10.1378/chest.121.2.329 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71481082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A83759039</galeid><els_id>S0012369216354320</els_id><sourcerecordid>A83759039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-970b8188fe2b1a3a1dee42712a147bb0bfdae156581a641cea6a28a11ed29bc63</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhSMEokvhzA1FSHAiW4-dTeLjqlCKVAGqytmaOJONS2KndhZUfj1mE2kRKvJhPKNv3ozmJclLYGsQZXWmOwrTGjis-Vpw-ShZgRSQiU0uHicrxoBnopD8JHkWwi2LOcjiaXICUIm8EHKVNDcdpdcmfE9dm166MJoJe_MLJ-NsirZJPxP67AJj9ZDOv22YugFTY9Nr6md2cukUpb6S1zQeKlHw_X0YLeHz5EmLfaAXSzxNvl18uDm_zK6-fPx0vr3K9KaCKZMlqyuoqpZ4DSgQGqKcl8AR8rKuWd02SLApIoxFDpqwQF4hADVc1roQp8nbWXf07m4fL6MGEzT1PVpy-6BKyCtgFY_g63_AW7f3Nu6mOGN5UUhRRujdDO2wJ2Vs6yaPekeWPPbOUmtieVuJciOZkBHPHsDja2gw-iH-bOa1dyF4atXozYD-XgFTf8xVB3NVNFdxFc2NHa-Wrff1QM2RX9yMwJsFwKCxbz1abcKRE3lZ5qU4ju7MrvtpPKkwYN9HWTEPXa7x92g5d1C074chr4I2ZDU1sVtPqnHmv2v_Blru0N8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200466937</pqid></control><display><type>article</type><title>The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Magadle, Rasmi ; Berar-Yanay, Noa ; Weiner, Paltiel</creator><creatorcontrib>Magadle, Rasmi ; Berar-Yanay, Noa ; Weiner, Paltiel</creatorcontrib><description>A life-threatening asthma attack is still of major concern. One of the main goals in treating patients with asthma is identification of the patients at risk of having these attacks. It has been shown that patients who have a near-fatal asthma attack have a blunted perception of dyspnea (POD). The purpose of this study is to measure the POD in patients with asthma, and to relate POD to life-threatening attacks within a 24-month follow-up period.
The POD was scored using the Borg scale during breathing against a progressive load at 1-min intervals, in order to achieve mouth pressure up to 30 cm H2O, in 113 consecutive asthmatic patients with stable asthma attending an outpatient clinic. All patients were invited to regular follow-up every 3 months for up to 24 months, and all hospitalizations and near-fatal and fatal asthma attacks were recorded. The prebronchodilator morning peak expiratory flow rate (PEFR), daily regular treatment, and β2-agonist consumption were recorded in a diary card for the first 4 weeks.
Seventeen patients (15%) had high POD compared to the normal subjects, 67 patients (59%) had POD within the normal range, and 29 patients (26%) had lower-than-normal POD. In the patients with low POD, there was a tendency for higher age, higher female/male ratio, and a longer duration of disease. The rate of severe asthma was higher in the low-POD group than in the normal-POD group, but did not differ from the rate in the high-POD group. The mean daily β2-agonist consumption in the patients with low POD was significantly lower (p < 0.01) than in the patients with high POD, although the mean PEFR was lower in the low-POD group. During the 2 years of follow-up, the patients in the low-POD group had statistically significantly more emergency department (ED) visits, hospitalizations, near-fatal asthma attacks, and deaths compared to the normal-POD and high-POD groups.
Approximately 26% of the referral subjects with asthma had low POD when compared to healthy matched subjects. Patients with low POD had statistically significantly more ED visits, hospitalizations, near-fatal asthma attacks, and deaths during the follow-up period. Reduced POD may predispose patients to a life-threatening attack.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.121.2.329</identifier><identifier>PMID: 11834639</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Age Factors ; Asthma ; Asthma - complications ; Asthma - drug therapy ; Asthma - mortality ; Asthma - physiopathology ; Biological and medical sciences ; Causes of ; Chronic obstructive pulmonary disease, asthma ; Complications and side effects ; Dyspnea ; Dyspnea - etiology ; Emergency medical care ; Emergency Service, Hospital - statistics & numerical data ; Female ; Hospitalization ; Humans ; life-threatening asthma attack ; Male ; Medical sciences ; Outpatient care facilities ; Peak Expiratory Flow Rate ; Perception ; perception of dyspnea ; Pneumology ; Shortness of breath</subject><ispartof>Chest, 2002-02, Vol.121 (2), p.329-333</ispartof><rights>2002 The American College of Chest Physicians</rights><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 Elsevier B.V.</rights><rights>Copyright American College of Chest Physicians Feb 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-970b8188fe2b1a3a1dee42712a147bb0bfdae156581a641cea6a28a11ed29bc63</citedby><cites>FETCH-LOGICAL-c581t-970b8188fe2b1a3a1dee42712a147bb0bfdae156581a641cea6a28a11ed29bc63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13477473$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11834639$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Magadle, Rasmi</creatorcontrib><creatorcontrib>Berar-Yanay, Noa</creatorcontrib><creatorcontrib>Weiner, Paltiel</creatorcontrib><title>The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea</title><title>Chest</title><addtitle>Chest</addtitle><description>A life-threatening asthma attack is still of major concern. One of the main goals in treating patients with asthma is identification of the patients at risk of having these attacks. It has been shown that patients who have a near-fatal asthma attack have a blunted perception of dyspnea (POD). The purpose of this study is to measure the POD in patients with asthma, and to relate POD to life-threatening attacks within a 24-month follow-up period.
The POD was scored using the Borg scale during breathing against a progressive load at 1-min intervals, in order to achieve mouth pressure up to 30 cm H2O, in 113 consecutive asthmatic patients with stable asthma attending an outpatient clinic. All patients were invited to regular follow-up every 3 months for up to 24 months, and all hospitalizations and near-fatal and fatal asthma attacks were recorded. The prebronchodilator morning peak expiratory flow rate (PEFR), daily regular treatment, and β2-agonist consumption were recorded in a diary card for the first 4 weeks.
Seventeen patients (15%) had high POD compared to the normal subjects, 67 patients (59%) had POD within the normal range, and 29 patients (26%) had lower-than-normal POD. In the patients with low POD, there was a tendency for higher age, higher female/male ratio, and a longer duration of disease. The rate of severe asthma was higher in the low-POD group than in the normal-POD group, but did not differ from the rate in the high-POD group. The mean daily β2-agonist consumption in the patients with low POD was significantly lower (p < 0.01) than in the patients with high POD, although the mean PEFR was lower in the low-POD group. During the 2 years of follow-up, the patients in the low-POD group had statistically significantly more emergency department (ED) visits, hospitalizations, near-fatal asthma attacks, and deaths compared to the normal-POD and high-POD groups.
Approximately 26% of the referral subjects with asthma had low POD when compared to healthy matched subjects. Patients with low POD had statistically significantly more ED visits, hospitalizations, near-fatal asthma attacks, and deaths during the follow-up period. Reduced POD may predispose patients to a life-threatening attack.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Asthma</subject><subject>Asthma - complications</subject><subject>Asthma - drug therapy</subject><subject>Asthma - mortality</subject><subject>Asthma - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Causes of</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Complications and side effects</subject><subject>Dyspnea</subject><subject>Dyspnea - etiology</subject><subject>Emergency medical care</subject><subject>Emergency Service, Hospital - statistics & numerical data</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>life-threatening asthma attack</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Outpatient care facilities</subject><subject>Peak Expiratory Flow Rate</subject><subject>Perception</subject><subject>perception of dyspnea</subject><subject>Pneumology</subject><subject>Shortness of breath</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kUFv1DAQhSMEokvhzA1FSHAiW4-dTeLjqlCKVAGqytmaOJONS2KndhZUfj1mE2kRKvJhPKNv3ozmJclLYGsQZXWmOwrTGjis-Vpw-ShZgRSQiU0uHicrxoBnopD8JHkWwi2LOcjiaXICUIm8EHKVNDcdpdcmfE9dm166MJoJe_MLJ-NsirZJPxP67AJj9ZDOv22YugFTY9Nr6md2cukUpb6S1zQeKlHw_X0YLeHz5EmLfaAXSzxNvl18uDm_zK6-fPx0vr3K9KaCKZMlqyuoqpZ4DSgQGqKcl8AR8rKuWd02SLApIoxFDpqwQF4hADVc1roQp8nbWXf07m4fL6MGEzT1PVpy-6BKyCtgFY_g63_AW7f3Nu6mOGN5UUhRRujdDO2wJ2Vs6yaPekeWPPbOUmtieVuJciOZkBHPHsDja2gw-iH-bOa1dyF4atXozYD-XgFTf8xVB3NVNFdxFc2NHa-Wrff1QM2RX9yMwJsFwKCxbz1abcKRE3lZ5qU4ju7MrvtpPKkwYN9HWTEPXa7x92g5d1C074chr4I2ZDU1sVtPqnHmv2v_Blru0N8</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Magadle, Rasmi</creator><creator>Berar-Yanay, Noa</creator><creator>Weiner, Paltiel</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><general>Elsevier B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20020201</creationdate><title>The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea</title><author>Magadle, Rasmi ; Berar-Yanay, Noa ; Weiner, Paltiel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-970b8188fe2b1a3a1dee42712a147bb0bfdae156581a641cea6a28a11ed29bc63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Asthma</topic><topic>Asthma - complications</topic><topic>Asthma - drug therapy</topic><topic>Asthma - mortality</topic><topic>Asthma - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Causes of</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Complications and side effects</topic><topic>Dyspnea</topic><topic>Dyspnea - etiology</topic><topic>Emergency medical care</topic><topic>Emergency Service, Hospital - statistics & numerical data</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>life-threatening asthma attack</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Outpatient care facilities</topic><topic>Peak Expiratory Flow Rate</topic><topic>Perception</topic><topic>perception of dyspnea</topic><topic>Pneumology</topic><topic>Shortness of breath</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magadle, Rasmi</creatorcontrib><creatorcontrib>Berar-Yanay, Noa</creatorcontrib><creatorcontrib>Weiner, Paltiel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magadle, Rasmi</au><au>Berar-Yanay, Noa</au><au>Weiner, Paltiel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>121</volume><issue>2</issue><spage>329</spage><epage>333</epage><pages>329-333</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>A life-threatening asthma attack is still of major concern. One of the main goals in treating patients with asthma is identification of the patients at risk of having these attacks. It has been shown that patients who have a near-fatal asthma attack have a blunted perception of dyspnea (POD). The purpose of this study is to measure the POD in patients with asthma, and to relate POD to life-threatening attacks within a 24-month follow-up period.
The POD was scored using the Borg scale during breathing against a progressive load at 1-min intervals, in order to achieve mouth pressure up to 30 cm H2O, in 113 consecutive asthmatic patients with stable asthma attending an outpatient clinic. All patients were invited to regular follow-up every 3 months for up to 24 months, and all hospitalizations and near-fatal and fatal asthma attacks were recorded. The prebronchodilator morning peak expiratory flow rate (PEFR), daily regular treatment, and β2-agonist consumption were recorded in a diary card for the first 4 weeks.
Seventeen patients (15%) had high POD compared to the normal subjects, 67 patients (59%) had POD within the normal range, and 29 patients (26%) had lower-than-normal POD. In the patients with low POD, there was a tendency for higher age, higher female/male ratio, and a longer duration of disease. The rate of severe asthma was higher in the low-POD group than in the normal-POD group, but did not differ from the rate in the high-POD group. The mean daily β2-agonist consumption in the patients with low POD was significantly lower (p < 0.01) than in the patients with high POD, although the mean PEFR was lower in the low-POD group. During the 2 years of follow-up, the patients in the low-POD group had statistically significantly more emergency department (ED) visits, hospitalizations, near-fatal asthma attacks, and deaths compared to the normal-POD and high-POD groups.
Approximately 26% of the referral subjects with asthma had low POD when compared to healthy matched subjects. Patients with low POD had statistically significantly more ED visits, hospitalizations, near-fatal asthma attacks, and deaths during the follow-up period. Reduced POD may predispose patients to a life-threatening attack.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>11834639</pmid><doi>10.1378/chest.121.2.329</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2002-02, Vol.121 (2), p.329-333 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_miscellaneous_71481082 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Age Factors Asthma Asthma - complications Asthma - drug therapy Asthma - mortality Asthma - physiopathology Biological and medical sciences Causes of Chronic obstructive pulmonary disease, asthma Complications and side effects Dyspnea Dyspnea - etiology Emergency medical care Emergency Service, Hospital - statistics & numerical data Female Hospitalization Humans life-threatening asthma attack Male Medical sciences Outpatient care facilities Peak Expiratory Flow Rate Perception perception of dyspnea Pneumology Shortness of breath |
title | The Risk of Hospitalization and Near-Fatal and Fatal Asthma in Relation to the Perception of Dyspnea |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Hospitalization%20and%20Near-Fatal%20and%20Fatal%20Asthma%20in%20Relation%20to%20the%20Perception%20of%20Dyspnea&rft.jtitle=Chest&rft.au=Magadle,%20Rasmi&rft.date=2002-02-01&rft.volume=121&rft.issue=2&rft.spage=329&rft.epage=333&rft.pages=329-333&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.121.2.329&rft_dat=%3Cgale_proqu%3EA83759039%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200466937&rft_id=info:pmid/11834639&rft_galeid=A83759039&rft_els_id=S0012369216354320&rfr_iscdi=true |